Genzyme Therapeutic Products Limited Partnership
Genzyme Therapeutic Products Limited Partnership, a prominent player in the biotechnology industry, is headquartered in the United States. Founded in the early 1980s, the company has established itself as a leader in developing innovative therapies for rare genetic disorders and other complex diseases. With a strong operational presence across North America and Europe, Genzyme focuses on areas such as enzyme replacement therapy and gene therapy.
The company’s core products, including treatments for conditions like Gaucher disease and Fabry disease, are distinguished by their commitment to patient-centric solutions and cutting-edge research. Genzyme's notable achievements include pioneering advancements in biopharmaceuticals, solidifying its market position as a trusted provider of specialised therapeutic products. Through continuous innovation and a dedication to improving patient outcomes, Genzyme Therapeutic Products Limited Partnership remains at the forefront of the biotechnology sector.
+71 vs industry average
Genzyme Therapeutic Products Limited Partnership’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Genzyme Therapeutic Products Limited Partnership?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Recreation and Sports Services has below-average carbon intensity
Industry performance
The Recreation and Sports Services industry has reduced its overall emissions by 2% since 2019
Reported emissions
No reported emissions data is available for Genzyme Therapeutic Products Limited Partnership yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Genzyme Therapeutic Products Limited Partnership’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Genzyme Therapeutic Products Limited Partnership yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Genzyme Therapeutic Products Limited Partnership yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project